A phosphatase mutant and its application in the preparation of fructose and psicose
By screening and optimizing phosphatase mutants and combining with the multi-enzyme catalytic system, the problem of low fructose yield in the existing technology was solved, and the preparation of high-effect sugars and paclitaxel was achieved, which improved the fructose conversion rate and paclitaxel. Preparation efficiency.
Patent Information
- Application Number
- CN202111512164.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-12-07
- Publication Date
- 2024-11-01
- Estimated Expiration
- 2041-12-07
AI Technical Summary
In the prior art, when preparing fructose in starch, the phosphatase activity and specificity of catalyzing the dephosphorylation reaction of fructose 6-phosphate is insufficient, resulting in a low yield of fructose, making it difficult to efficiently prepare fructose and its derivative paclitolose.
By screening and obtaining phosphatase mutants with specific amino acid site mutations, combining with multi-enzyme catalytic systems, including glucose phosphate mutagenesis, glucose phosphate isomerase and fructose 6-phosphate phosphatase, the reaction conditions are optimized To improve fructose conversion and paclitaxel preparation efficiency.
The fructose conversion rate is achieved by more than 90%, and the fructose content accounts for more than 90% of the total sugar. It is suitable for preparing high fructose syrup and reduces the production cost of paclitaxel.
Smart Images

Figure CN116240196B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the field of biotechnology, and in particular relates to a mutant of phosphatase and a fructose biological preparation method thereof. Background Art
[0002] Fructose is a monosaccharide and is a new type of healthy sugar source known so far. It is 1.2 to 1.8 times sweeter than sucrose and exists naturally in fruit, honey and cereal juice. Fructose has a fruity aroma and low calorific value. It is not easily converted into acid by streptococci in the mouth, thus inhibiting the formation of dental caries. Its peak sweetness comes and goes quickly, and the sweetness does not affect other aromas, which has the effect of enhancing the flavor of the product. Fructose has good solubility and is quickly absorbed by the human body. It can quickly replenish the body's energy and is the main source of physical energy for people who exercise and consume a lot of physical energy. Foreign countries have developed various nutritional, energy and refreshing solid beverages using this characteristic.
[0003] Fructose Special medical formula foods containing crystalline fructose are gradually being accepted by more and more consumers. As a new generation of high-energy nutritional infusion that does not rely on insulin, fructose injection is very active in the world pharmaceutical market. It has been included in the pharmacopoeia of the United States, Britain, Germany, Japan and other countries, and has become the second largest injection after glucose. Glycerol fructose infusion, fructose sodium chloride injection and fructose Vc tablets have been used to treat cardiovascular diseases, diabetes, brain cranial diseases and liver diseases; fructose can also accelerate the metabolism of ethanol and can be used to treat ethanol poisoning. Therefore, fructose has become an important raw material for many food, health products, medicines and other products with its unique advantages.
[0004] At present, the large-scale production of fructose in industry mainly adopts starch hydrolysis to produce glucose, which is converted into fructose and fructose-rich syrup by immobilized glucose isomerase, and then separated and crystallized to obtain crystalline fructose. There are also related studies that directly hydrolyze, separate and crystallize sucrose to obtain fructose. The above method is used to obtain high fructose syrup and crystalline fructose with high fructose content, which requires a complex chromatographic separation process. The literature (A Biomimetic Biotechnological Process for Converting Starch to Fructose: Thermodynamic and Evolutionary Considerations in Applied Enzymology. J. Am. Chem. SOC. 1992, 114, 6980-6987) discloses the route and ideas for preparing fructose from starch. This method is based on phosphorylation and dephosphorylation reactions, and compared with the traditional method of preparing fructose by glucose, it is possible to have a higher conversion rate. Patent WO2018169957A1 also discloses a method for preparing fructose from starch, and also discloses the sources and reaction conditions of each enzyme in the route. However, the patent document discloses many methods for preparing many products from starch, and for the implementation plan for preparing fructose from starch, although the reaction conditions are indicated, the actual conversion rate is not given. The key to the route of preparing fructose from starch lies in the phosphatase that catalyzes the synthesis of fructose 6-phosphate into fructose. The high activity and catalytic specificity of the enzyme directly determine the fructose yield. Therefore, how to catalyze the dephosphorylation reaction of fructose 6-phosphate into fructose with high catalytic activity and good specificity is the key to realizing the preparation of fructose from starch.
[0005] D-psicose is a diastereomer of fructose, with a sweetness of 70% of sucrose and low calories. It is an ideal low-calorie sweetener and can be used as a sucrose substitute in the food field. It has been officially approved by the U.S. Food and Drug Administration (FDA) as a GRAS food, allowing it to be used in food, pharmaceutical preparations and dietary supplements. The traditional method of preparing allulose relies on bioconversion of fructose to synthesize allulose, and the production cost of fructose is much higher than that of starch. Therefore, if an efficient route for preparing fructose from starch is established, and then a cascade isomerization reaction is used to synthesize allulose, it will help to achieve low-cost preparation of allulose. Summary of the invention
[0006] The mutant of phosphatase obtained by research and screening of the present invention is characterized in that it has mutations at the following amino acid sites relative to SEQ ID NO.1: a single position of 122, 126, 149, 178, 181 and 175 has a substitution mutation, or multiple positions have a substitution mutation.
[0007] Preferably, the following amino acid positions exist relative to SEQ ID NO.1: position 122 mutates to Y, H or Q, or position 126 mutates to T, H, E or F, or position 149 mutates to M or E, or position 178 mutates to H or S, position 181 mutates to M, H, F or K, and position 175 mutates to A or R.
[0008] More preferably, it has mutations in the following combinations of amino acid positions relative to SEQ ID NO.1: mutations at positions 122 and 126, mutations at positions 122 and 149, mutations at positions 122 and 178, mutations at positions 122 and 181, mutations at positions 122 and 175; mutations at positions 126 and 149, mutations at positions 126 and 178, mutations at positions 126 and 181, mutations at positions 126 and 175; mutations at positions 149 and 1178, mutations at positions 149 and 181, mutations at positions 149 and 175; mutations at positions 178 and 181, mutations at positions 178 and 1175; mutations at positions 181 and 175 There are mutations at positions 122, 126, and 149; there are mutations at positions 126, 149, and 178; there are mutations at positions 178, 181, and 175; there are mutations at positions 122, 126, 149, and 178; there are mutations at positions 126, 149, 178, and 181; Mutations exist at positions 49, 178, 181 and 175 simultaneously; mutations exist at positions 122, 126, 149, 178 and 181 simultaneously; mutations exist at positions 126, 149, 178, 181 and 175 simultaneously; mutations exist at positions 122, 126, 149, 178, 181 and 175 simultaneously.
[0009] The present invention further provides the use of the mutant of the phosphatase in synthesizing fructose.
[0010] Specifically, starch, maltodextrin, sucrose and glucose are used as substrates.
[0011] In one embodiment, when starch substrate is used, the reaction system contains the following enzymes:
[0012] (1) glucan phosphorylase GP, which catalyzes the conversion of maltodextrin into glucose 1-phosphate; (2) glucose phosphomutase PGM, which catalyzes the conversion of glucose 1-phosphate into glucose 6-phosphate; (3) glucose phosphoisomerase: glucan phosphorylase, glucose phosphomutase, glucose phosphoisomerase, and the phosphatase mutant according to any one of claims 1 to 4; preferably, the reaction system contains starch, Mg 2+ , glucan phosphorylase, glucose phosphomutase, glucose phosphotisomerase, and the phosphatase mutants; more preferably, glucan phosphorylase is derived from Thermotogamaritima, and the gene number on KEGG is TM1168, glucose phosphomutase is derived from Thermotogamaritima, and the gene number on KEGG is TM0769; glucose phosphotisomerase PGI is selected from Thermusthermophilus, and its label on UniProt is A3DBX9.
[0013] Preferably, the reaction system also contains glucose isomerase, glucose kinase and polyphosphate kinase; preferably, glucose isomerase is derived from Thermus thermophilus, and the gene number on Uniprot is P26997; glucose kinase is derived from Thermobifida fusca, and the gene number on KEGG is Tfu_1811; polyphosphate kinase is derived from Thermus thermophilus, and the gene number on KEGG is TT_C0637.
[0014] More preferably, in the reaction system, the concentration of starch is 1-500 g / L, the concentration of phosphate is 1-100 mM, the amount of glucan phosphorylase is 0.1-1000 U / mL, the amount of glucose phosphomutase is 0.1-1000 U / mL, the amount of glucose phosphomutase is 0.1-1000 U / mL, the amount of glucose phosphomonase is 0.1-1000 U / mL, and the amount of fructose 6-phosphate phosphatase is 0.1-1000 U / mL.
[0015] The preferred concentration of maltodextrin is 100 g / L, the phosphate concentration is 20 mM, the dosage of glucan phosphorylase is 10 U / mL, the dosage of glucose phosphomutase is 10 U / mL, the dosage of glucose phosphomutase is 10 U / mL, and the dosage of fructose 6-phosphate phosphatase is 10 U / mL.
[0016] The enzyme-catalyzed reaction conditions are 10-80° C. and the reaction time is 1-120 hours; preferably 60° C. and the reaction time is 48-96 hours.
[0017] In order to further improve the conversion rate, starch can be treated with isoamylase or directly added to the reaction system, and the addition amount of isoamylase is 0.1-1000U / mL, preferably 0.5U / mL.
[0018] To further improve the conversion rate, 4-glucanotransferase can be added to the reaction system, and the dosage of 4-glucanotransferase is 0.1-1000 U / mL, preferably 0.5 U / mL.
[0019] In order to further improve the conversion rate, glucose kinase and polyphosphate kinase are added to the system. The dosage of glucose kinase is 0.1-1000U / mL, the dosage of polyphosphate kinase is 0.1-1000U / mL, and the dosage of glucose kinase is preferably 0.5U / mL, and the dosage of glucose isomerase is 0.5U / mL.
[0020] In another embodiment, when sucrose is used as a substrate, the reaction system contains the following enzymes: sucrose phosphorylase, glucose phosphotyrosinase, glucose phosphotyrosinase, and the phosphatase mutant according to any one of claims 1 to 3; preferably, the reaction system contains sucrose, Mg 2+ , ATP, and sucrose phosphorylase, glucose phosphomutase, glucose phosphomutase and the phosphatase mutants; preferably, the sucrose phosphorylase is derived from Bifidobacteriumadolescentis, and the gene number on KEGG is A0ZZH6.
[0021] In a specific embodiment, the reaction is carried out at 50-60° C. for 16-32 hours; after the reaction is completed, the reaction is terminated by heating in a boiling water bath.
[0022] In the reaction system, the concentration of sucrose is 1-500 g / L, the concentration of phosphate is 1-100 mM, the dosage of sucrose phosphorylase is 0.1-1000 U / mL, the dosage of glucose phosphomutase is 0.1-1000 U / mL, the dosage of glucose phosphomutase is 0.1-1000 U / mL, the dosage of fructose 6-phosphate phosphatase is 0.1-1000 U / mL, the dosage of glucose kinase is 0.1-1000 U / mL, and the dosage of polyphosphate kinase is 0.1-1000 U / mL.
[0023] The preferred sucrose concentration is 340 g / L, the phosphate concentration is 50 mM, the amount of sucrose phosphorylase is 10 U / mL, the amount of glucose phosphomutase is 10 U / mL, the amount of glucose phosphomutase is 10 U / mL, the amount of glucose phosphomonase is 10 U / mL, the amount of fructose 6-phosphate phosphatase is 10 U / mL, the amount of glucose isomerase is 10 U / mL, the amount of glucose kinase is 10 U / mL, and the amount of polyphosphate kinase is 10 U / mL.
[0024] The enzyme-catalyzed reaction conditions are 10-80° C. and the reaction time is 1-120 hours; preferably 55° C. and the reaction time is 24 hours.
[0025] Furthermore, the present invention provides the use of the mutant of the phosphatase in synthesizing psicose, preferably with starch, maltodextrin, sucrose and glucose as substrates.
[0026] In a specific embodiment, when starch is used as a substrate, the reaction system contains the following enzymes: glucan phosphorylase, glucose phosphomutase, glucose phosphoisomerase, isoamylase, glucanotransferase, psicose 3-epimerase and the phosphatase mutant; preferably, the reaction system contains starch, Mg 2+ , glucan phosphorylase, glucose phosphomutase, glucose phosphomutase, isoamylase, glucanotransferase, psicose 3-epimerase and the phosphatase mutants;
[0027] In another embodiment, when sucrose is used as a substrate, the reaction system contains the following enzymes: sucrose phosphorylase, glucose phosphomutase, glucose phosphoisomerase, psicose 3-epimerase and the phosphatase mutant; preferably, the reaction system contains sucrose, Mg 2+ , ATP, and sucrose phosphorylase, glucose phosphomutase, glucose phosphomumetase, psicose 3-epimerase and the phosphatase mutants.
[0028] The present invention obtains mutants of single-site mutations by a large number of screenings, and further obtains combined mutations by saturation mutations. Experiments show that compared with the wild type, the final fructose conversion rate exceeds 90%, and the fructose content in the final product system accounts for more than 90% of the total sugar, which is very suitable for preparing high fructose syrup. At the same time, the present invention is also very suitable for preparing allulose. Therefore, the present invention has a high application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] Figure 1 Starch / maltodextrin / sucrose synthesized fructose technology route. DETAILED DESCRIPTION
[0030] The present invention is further described in detail below with reference to the examples.
[0031] The percentage concentrations mentioned in the present invention and the examples are all mass / mass (W / W, unit: g / 100 g) percentage concentrations, mass / volume (W / V, unit: g / 100 mL) percentage concentrations or volume / volume (V / V, unit: mL / 100 mL) percentage concentrations unless otherwise specified.
[0032] The methods used in the following examples are all conventional methods unless otherwise specified. For specific steps, please refer to: "Molecular Cloning: A Laboratory Manual" (Sambrook, J., Russell, David W., Molecular Cloning: A Laboratory Manual, 3rd edition, 2001, NY, Cold Spring Harbor).
[0033] Materials or reagents with the same names used in the examples are the same unless otherwise specified. The methods for obtaining various biological materials described in the examples are only to provide an experimental method for obtaining them to achieve the specific disclosed purpose, and should not be a limitation on the source of biological materials when implementing the present invention. In fact, the sources of biological materials used are extensive, and any biological materials that can be obtained without violating laws and moral ethics can be replaced and used according to the instructions in the examples.
[0034] The primers and genes used in the present invention were synthesized by Jiangsu Jinweizhi Biotechnology Co., Ltd.
[0035] The embodiments are implemented on the premise of the technical solution of the present invention, and detailed implementation methods and specific operation processes are given. The embodiments will help to understand the present invention, but the protection scope of the present invention is not limited to the following embodiments. It should be understood by those skilled in the art that the details and forms of the technical solution of the present invention can be modified or replaced without departing from the spirit and scope of the present invention, but these modifications or replacements all fall within the protection scope of the present invention.
[0036] Example 1 Acquisition of phosphatase F6PP gene and vector construction
[0037] The phosphatase sequence (SEQ ID NO.1) derived from Thermotoga sp. 38H, whose amino acid sequence was codon-optimized and whose gene sequence had a nucleotide sequence after the preferred codon of Escherichia coli (SEQ ID NO.2), was sent to Jiangsu Jinweizhi Biotechnology Co., Ltd. for gene synthesis and constructed into the expression vector pET-21a.
[0038] Example 2 Gene expression and purification
[0039] The recombinant plasmid containing the above phosphatase gene (the optimized sequence SEQ ID NO.2) was transferred into Escherichia coli for exogenous expression and purification.
[0040] (1) The E. coli expression recombinant plasmid pET-F6PP was transformed into E. coli BL21 (DE3) to obtain recombinant bacteria.
[0041] (2) Pick a single clone and transfer it to 5 mL LB liquid medium. Cultivate at 37°C and 220 rpm until OD 600 Transfer 5 mL of the bacterial solution in LB medium to 800 mL of 2YT medium and culture at 37°C and 220 rpm until the OD 600 When the pH value was 0.6-0.8, the temperature was lowered to 16°C, IPTG was added to a final concentration of 0.5 mM, and the expression was induced for 16 h.
[0042] (3) Collect the above culture solution into a 50 mL centrifuge tube and centrifuge at 5500 rpm for 15 min;
[0043] (4) Discard the supernatant and resuspend the cells in 2 mL of triethanolamine buffer, pH 7.5.
[0044] (5) Bacterial disruption: Use a high-pressure low-temperature disruptor at a pressure of 1200 bar and 4°C for two times. Centrifuge at 4°C and 20,000 rpm for 45 min.
[0045] (6) Purification: The supernatant was heat treated in a 70°C water bath for 20 min, centrifuged at 4°C and 20,000 rpm for 45 min, and the supernatant was collected to obtain the pure protein.
[0046] Example 3 Phosphatase activity assay
[0047] The dephosphorylation activity of the purified phosphatase was determined for fructose 6-phosphate. The enzyme activity assay system included the following: fructose 6-phosphate (20 mM), Mg 2+ (1mM), phosphate buffer (pH 7.5, 50mM), enzyme (0.5mg / mL), 55℃, reaction for 10min. Enzyme activity definition (1U): The amount of mannose catalyzed by each mg of M6PP per minute is 1 micromole. The sample was subjected to high performance liquid chromatography. The enzyme activity obtained by calculation and analysis is shown in Table 1. The enzyme activity of Ts-F6PP is 0.7U / mg.
[0048] Example 4. Construction of a Ts-F6PP mutant library
[0049] 1. The primers used in the error-prone PCR are designed as follows:
[0050] P3: ATGTACCGTGTTTTCGTTTTCGACCT
[0051] P4: CCGCTCGAGTTAGCATTCCAGGTGACGGG
[0052] 2. Using the gene of the glycerol glucoside phosphorylase synthesized in Example 1 as a template, the above-mentioned primers and random mutation PCR kit were used to perform PCR amplification using the gene of the wild-type glycerol glucoside phosphorylase as a template, and the PCR product was excised and recovered, and after being treated with restriction endonucleases NdeI and XhoI, it was ligated with the pET21a vector that had also been double-digested, and transformed into Escherichia coli BL21 (DE3) competent state, mutated LB plates (containing 100 μg / mL ampicillin), and cultured at 37°C overnight. After the transformants grew out, a single transformant was picked up with a sterilized toothpick and placed in a 96-well plate, 1 mL of LB liquid culture medium was added to each well, and after culturing at 37°C for 6 h, a final concentration of 0.1 mM IPTG was added, and the temperature was lowered to 16°C for induction overnight.
[0053] 3. Centrifuge the 96-well plate cultured above, discard the supernatant, resuspend the bacterial pellet with 50 mM MES (pH = 6.5), add lysozyme, treat at 37°C for 1 h, and freeze-thaw twice to obtain Escherichia coli cell lysate containing glycerol glucoside phosphorylase.
[0054] 4. Take 20 μL of the above E. coli cell lysate to determine the activity and thermal stability of the mutant, and obtain the mutation site with improved activity or thermal stability.
[0055] Example 5 Phosphatase catalytic specificity screening experiment
[0056] An in vitro multi-enzyme catalytic system was established, and the catalytic specificity of different types of phosphatases was determined by detecting the concentrations of fructose and glucose in the system. The in vitro multi-enzyme catalytic system for converting maltodextrin to fructose includes: (1) glucan phosphorylase GP, which catalyzes the conversion of maltodextrin to glucose 1-phosphate; (2) phosphoglucomutase PGM, which catalyzes the conversion of glucose 1-phosphate to glucose 6-phosphate; (3) phosphoglucoisomerase PGI, which can directly catalyze the conversion of glucose 6-phosphate to fructose 6-phosphate; (4) fructose 6-phosphate phosphatase Ts-F6PP, which catalyzes the dephosphorylation of fructose 6-phosphate to produce fructose.
[0057] In the present invention, glucan phosphorylase is derived from Thermotoga maritima, and the gene number on KEGG is TM1168; glucose phosphomutase is derived from Thermotoga maritima, and the gene number on KEGG is TM0769; glucose phosphoisomerase PGI is selected from Thermus thermophilus, and its number on UniProt is A3DBX9; fructose 6-phosphate phosphatase selects Ts-F6PP mutant. Among them, glucan phosphorylase GP, glucose phosphomutase PGM, glucose phosphoisomerase PGI, these three genes are obtained from corresponding genomic DNA by PCR using different primers, and cloned into pET21 vector by enzyme cutting and ligation method to obtain corresponding expression vectors pET21-GP, pET21-PGM, pET21-PGI.
[0058] The following reaction system was established: 30 mM phosphate buffer (pH 7.0), 5 mM magnesium chloride, the concentration of starch was 10 g / L, the amount of glucan phosphorylase was 2 U / mL, the amount of glucose phosphomutase was 2 U / mL, the amount of glucose phosphomonate PGI was 2 U / mL, and the amount of Ts-F6PP mutant was 2 U / mL. The catalytic reaction was carried out at 55 ° C for 24 hours, and the final sample of the reaction was subjected to liquid chromatography detection. Assuming that Ts-F6PP has good specificity for glucose 6-phosphate, the glucose concentration in the reaction system is high; assuming that Ts-F6PP has good specificity for fructose 6-phosphate, the fructose concentration in the reaction system is high. Therefore, by calculating the ratio of fructose to the total fructose and glucose content in the reaction system, a mutant with good specificity is screened.
[0059] Table 1 Comparison of specificity of different Ts-F6PP mutants
[0060]
[0061]
[0062] According to the results in Table 1, a total of 16 mutants with significantly improved specificity were obtained compared with the wild-type Ts-F6PP. Screening revealed that amino acid mutations at positions 122, 126, 149, 178, 181, and 175 had a greater impact on the catalytic specificity of fructose 6-phosphate, with the proportion of fructose being increased from 4% to 75.2%.
[0063] Example 6 Combination mutations at sites that increase catalytic specificity
[0064] The mutants with significantly improved relative specificity were subjected to rounds of combined mutation with other sites, and the specificity of the combined mutants was calculated based on the screening method of Example 5. The results are shown in Table 2:
[0065] Table 2 Combination mutants with significantly improved catalytic specificity
[0066]
[0067]
[0068]
[0069]
[0070] The present invention provides combined mutation sites and / or mutants capable of increasing the activity of fructose 6-phosphate phosphatase. After extensive screening, it was found that a combination of mutation sites and / or mutants mutated at one or more positions selected from 122, 126, 149, 178, 181 and 175, the combination of the above sites can further increase the fructose proportion from 75% of a single point mutation to a maximum of 96%.
[0071] Example 7 In vitro multi-enzyme catalytic system converts starch into fructose
[0072] The following reaction system was established: 30 mM phosphate buffer (pH 7.0), 5 mM magnesium chloride, the concentration of the starch was 100 g / L, the amount of glucan phosphorylase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase PGI was 10 U / mL, the amount of fructose 6-phosphate phosphatase was 10 U / mL, the amount of isoamylase IA was 0.5 U / mL, the amount of glucan transferase 4GT was 0.5 U / mL, the catalytic reaction was carried out at 55° C., the reaction was reacted for 24 hours, and the final reaction sample was detected by liquid chromatography.
[0073] Among them, isoamylase IA, which catalyzes starch debranching to produce amylose; 4-glucanotransferase, which catalyzes the polymerization of maltobiose and maltotriose to produce dextrin with higher length polymerization degree, is convenient for glucan phosphorylase GP to catalyze. Isoamylase is derived from Sulfolobus tokodaii, and the gene is numbered ST0928 on KEGG. Glucan transferase is derived from Thermococcus litoralis, and the gene is numbered OCC_10078 on KEGG. The above two genes are obtained by PCR amplification from the corresponding genome DHA with different primers, and cloned into the expression vector pET21 by enzyme cutting and connection method to obtain recombinant expression vectors pET21-IA and pET21-GT. The sources of the remaining enzymes are the same as in Example 6. The experimental results are shown in Table 3 below.
[0074] Table 3 Comparison of results of converting maltodextrin to prepare fructose
[0075]
[0076]
[0077] In order to further improve the conversion rate, glucose isomerase, glucose kinase and polyphosphate kinase can be added to the reaction system. Among them, glucose isomerase is derived from Thermus thermophilus, and the gene number on Uniprot is P26997; glucose kinase is derived from Thermobifida fusca, and the gene number on KEGG is Tfu_1811; polyphosphate kinase is derived from Thermus thermophilus, and the gene number on KEGG is TT_C0637; these genomic DNAs can be obtained from the official website of ATCC (www.atcc.org). These four genes are obtained from the corresponding genomic DNA by PCR using different primers, and cloned into the pET21 vector by enzyme cutting and ligation method to obtain the corresponding expression vectors pET21-GI, pET21-PPK and pET21-PPGK.
[0078] The above three enzymes were added into the reaction system for reaction under the same reaction conditions as before. The experimental results showed that the fructose conversion rate was increased to 90-96%, and no glucose was detected in the reaction system.
[0079] Example 7 In vitro multi-enzyme catalytic conversion of sucrose to fructose
[0080] An in vitro multi-enzyme catalytic system was established to convert sucrose into fructose. These key enzymes include: (1) sucrose phosphorylase SP, which catalyzes the conversion of sucrose into glucose 1-phosphate and fructose, (2) glucose phosphomutase PGM, (3) glucose phosphomitomerase PGI, and (4) fructose 6-phosphate phosphatase M6PP.
[0081] In the present invention, sucrose phosphorylase is derived from Bifidobacteriumadolescentis, the gene number of which is A0ZZH6 in KEGG, and is constructed into the expression vector pET-21a. This plasmid is transformed into Escherichia coli BL21 (DE3) (Invitrogen, Carlsbad, CA), and protein expression and purification are performed.
[0082] The following reaction system was established: 30 mM phosphate buffer (pH 7.0), 5 mM magnesium chloride, 5 mM ATP, 250 mM polyphosphate, the concentration of sucrose was 100 g / L, the amount of sucrose phosphorylase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomonase was 10 U / mL, the amount of fructose 6-phosphate phosphatase was 10 U / mL, the catalytic reaction was carried out at 55° C., the reaction was reacted for 24 hours, and the final reaction sample was subjected to liquid chromatography detection.
[0083] The results are shown in Table 4.
[0084] Table 4 Comparison of results of converting sucrose to produce fructose
[0085]
[0086] The results showed that after the reaction, the final fructose conversion rate of the mutants used exceeded 90%, and the fructose content in the final product system accounted for more than 90% of the total sugar, which is very suitable for the preparation of high fructose syrup.
[0087] Example 8: In vitro multi-enzyme catalytic system converts starch into psicose
[0088] The following reaction system was established: 30 mM phosphate buffer (pH 7.0), 5 mM magnesium chloride, the concentration of the starch was 100 g / L, the amount of glucan phosphorylase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of isoamylase IA was 0.5 U / mL, the amount of glucan transferase 4GT was 0.5 U / mL, the amount of psicose 3-epimerase was 10 U / mL, the catalytic reaction was carried out at 55° C., the reaction was reacted for 24 hours, and the final reaction sample was detected by liquid chromatography.
[0089] Among them, allulose 3-epimerase catalyzes the conversion of fructose into psicose. The enzyme is derived from Ruminococcus sp., and the nucleotide sequence of its encoded protein is shown in SE QID NO.3. After gene synthesis, the expression vector pET21 was constructed to obtain the expression vector pET21-DPE, which was then transferred into Escherichia coli BL21, and the protein was expressed and purified.
[0090] The results are shown in Table 5:
[0091] Table 5 Comparison of the results of converting maltodextrin to prepare psicose
[0092] Mutants Conversion rate (%) M24 28.2 M53 28.8 M58 28.5 M61 28.9 M63 28.8 M64 28.3 M69 28.9 M70 28.5 M71 28.5 M72 28.4 M73 29.1 M74 29.3 M79 29.1 M101 29.3 M103 29.6 M106 30 M108 30.1 M110 29.1 M114 29.3 M117 29.5 M118 29.7 M119 29.2 M123 29.8 M124 29.9 M134 29.9 M143 29.8 M144 29.9 M145 29.5 M146 29.1 M147 29.9 M148 30.2 M149 30.1
[0093] In the above reaction system, starch is used to directly prepare allulose, and after the reaction is balanced, the conversion rate is maintained between 28% and 30%.
[0094] Example 9 In vitro multi-enzyme catalytic conversion of sucrose to psicose
[0095] An in vitro multi-enzyme catalytic system was established to convert sucrose to psicose. These key enzymes include: (1) sucrose phosphorylase SP, which catalyzes the conversion of sucrose into glucose 1-phosphate and fructose, (2) phosphoglucomutase PGM, (3) phosphoglucoisomerase PGI, (4) fructose 6-phosphate phosphatase M6PP, and (5) psicose 3-epimerase.
[0096] The following reaction system was established: 30 mM phosphate buffer (pH 7.0), 5 mM magnesium chloride, 5 mM ATP, 250 mM polyphosphate, the concentration of sucrose was 100 g / L, the amount of sucrose phosphorylase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomutase was 10 U / mL, the amount of glucose phosphomumetase was 10 U / mL, the amount of fructose 6-phosphate phosphatase was 10 U / mL, and the amount of psicose 3-epimerase was 10 U / mL. The catalytic reaction was carried out at 55° C. for 24 hours, and the final reaction sample was detected by liquid chromatography.
[0097] The results are shown in Table 6.
[0098] Table 6 Comparison of results of converting sucrose to produce fructose
[0099]
[0100]
[0101] In the above reaction system, starch is used to directly prepare allulose, and after the reaction is balanced, the conversion rate is maintained between 27% and 30%. <110> Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences <120> A phosphatase mutant and its application in the preparation of fructose and psicose <130> <160> 3 <170> PatentIn version 3.5 <210> 1 <211> 268 <212> PRT <213> Thermotoga sp. 38H <400> 1 MYRVFVFDLDGTLLNDNLEISEKDRKVIERLSRKCHVVFASGRMLVSTLNVEKKYFGRTFPTIAYNGAMVYIPEEGVILKEKISPEVAKDIVEYIKPFNVHWQAYIDDVLYSERDNEEIRGYAKHSSVEYRVEPNLLELVSKVGTTKILLIDTPERLDELKKILSEKFNDVVKVFKSFPTYLEIVPENVDKGKALRFLREMGWKKEEIVVFGDNENDLFMFEEAGLRVAMGNAIDKVKEAADVVTLTNNDSGVSYVLELISTDCLDG 268 <210> 2 <211> 807 <212> DNA <213> artificial sequence <400> 2 ATGTACCGTGTTTTCGTTTTCGACCTGGACGGTACCCTGCTGAACGACAACCTGGAAATCTCTGAAAAAGACCGTAAAGTTATCGAACGTCTGTCTCGTAAATGCCACGTTGTTTTCGCTTCTGGTCGTATGCTGGTTTCTACCCTGAACGTTGAAAAAAAATACTTCGGTCGTACCTTCCCGACCATCGCTTACAACGGTGCTATGGTTTACATCCCGGAAGAAGGTGTTATCCTGAACGAAAAAATCTCTCCGGAAGTTGCTAAAGACATCGTTGAATACATCAAACCGTTCAACGTTCACTGGCAGGCTTACATCGACGACGTTCTGTACTCTGAACGTGACAACGAAGAAATCCGTGGTTACGCTAAACACTCTTCTGTTGAATACCGTGTTGAACCGA ACCTGCTGGAACTGGTTTCTAAAGTTGGTACCACCAAAATCCTGCTGATCGACACCCCGGAACGTCTGGACGAACTGAAAAAAATCCTGTCTGAAAAATTCAACGACGTTGTTAAAGTTTTCAAATCTTTCCCGACCTACCTGGAAATCGTTCCGGAAAACGTTGACAAAGGTAAAGCTCTGCGTTTCCTGCGTGAACGTATGGGTTGGAAAAAAGAAGAAATCGTTGTTTTCGGTGACAACGAAAACGACCTGTTCATGTTCGAAGAAGCTGGTCTGCGTGTTGCTATGGGTAACGCTATCGACAAAGTTAAAGAAGCTGCTGACGTTGTTACCCTGACCAACAACGACTCTGGTGTTTCTTACGTTCTGGAACTGATCTCTACCGACTGCCTGGACGGTTAA 807 <210> 3 <211> 876 <212> DNA <213> Ruminococcus sp. <400> 3 ATGAAATATGGTATTTATTACGCTTATTGGGAAAAGGAATGGAATGGAGATTACAAAATATTATATAGATAAAATTTCAAAATTAGGTTTTGATATTCTGGAAAATTTCTTGCGGCGCTTTTTCTGACTATTACACGAAAGATCAGGAGTTAATTGATATTGGAAAATATGCGAAAGAAAAAGGCGTAACATTGACAGCAGGGTATGGACCTCATTTTAATGAAAGCCTGTCATCTTCAGAACCCAATACGCAGAAACAAGCAATCAGTTTTTGGAAAGAGACGCTCCGGAAATTGAAGTTAATGGATATTCATATTGTTGGAGGCGCACTCTATGGTTATTGGCCTGTAGATTATTCCAAACCTTTTGATAAGAAAAGGGATTTAGAGAATTCCATTAAAAACATGAAAATTATTAGTCAGTATGCTGAAGAATATGAC ATAATGATGGGGATGGAAGTTCTTAACCGTTTTGAAGGCTATATGTTGAATACATGCGATGAAGCGTTGGCATACGTTGAAGAGGTTGGCTCTTCTAATGTTGGTGTTATGTTAGATACTTTTCACATGAATATAGAGGAAGATAATATAGCAGCAGCCATTCGTAAAGCAGGAGATAGGCTTTATCACTTCCATATAGGAGAAGGAAATCGTAAAGTACCAGGAAAAGGTATGCTTCCTTGGAATGAGATAGGACAGGCATTGCGAGATATAAACTACCAACATGCAGCAGTTATGGAGCCATTTGTAATGCAGGGAGGAACAGTAGGGCATGACATTAAAATATGGAGAGATATCATTGGAAACTGTTCTGAAGTTACATTAGATATGGACGCTCAAAGTGCGTTGCACTTTGTAAAACATGTATTTGAAGTCTAA 876
Claims
1. A phosphatase mutant, characterized in that: Compared with SEQ ID NO.1, the following amino acid position mutations exist: position 126 mutates to F, and position 181 mutates to H.
2. Use of the mutant of phosphatase as claimed in claim 1 in synthesizing fructose, wherein starch, maltodextrin, sucrose or glucose is used as substrate.
3. The use according to claim 2, characterized in that When starch is used as substrate, the reaction system contains the following enzymes: (1) glucan phosphorylase, which catalyzes the conversion of maltodextrin into glucose 1-phosphate; (2) glucose phosphomutase, which catalyzes the conversion of glucose 1-phosphate into glucose 6-phosphate; (3) glucose phosphoisomerase, and the phosphatase mutant as claimed in claim 1.
4. The use according to claim 3, characterized in that The reaction system contains starch, Mg 2+ , glucan phosphorylase, glucose phosphomutase, glucose phosphomutase, and the phosphatase mutant as described in claim 1.
5. The use according to claim 4, characterized in that The glucan phosphorylase is derived from Thermotogamaritima, and the gene number on KEGG is TM1168. The glucose phosphoglucomutase is derived from Thermotogamaritima, and the gene number on KEGG is TM0769. The glucose phosphoglucoisomerase PGI is derived from Thermus thermophilus , and its number in UniProt is A3DBX9.
6. The use according to claim 5, characterized in that The reaction system also contains glucose isomerase, glucose kinase and polyphosphate kinase.
7. The use according to claim 6, characterized in that The glucose isomerase is derived from Thermus thermophilus, and the gene number on Uniprot is P26997; the glucose kinase is derived from Thermobifida fusca, and the gene number on KEGG is Tfu_1811; the polyphosphate kinase is derived from Thermus thermophilus, and the gene number on KEGG is TT_C0637.
8. The use according to claim 2, characterized in that When sucrose is used as a substrate, the reaction system contains the following enzymes: sucrose phosphorylase, glucose phosphomutase, glucose phosphomitomerase and the phosphatase mutant as claimed in claim 1.
9. The use according to claim 8, characterized in that The reaction system contains sucrose, Mg 2+ , ATP, and sucrose phosphorylase, glucose phosphomutase, glucose phosphomumerase and the phosphatase mutant as claimed in claim 1.
10. The use according to claim 9, characterized in that The sucrose phosphorylase is derived from Bifidobacteriumadolescentis, and the gene number on UniProt is A0ZZH6.
11. Use of the mutant of phosphatase according to claim 1 in synthesizing psicose, wherein starch, maltodextrin, sucrose or glucose is used as substrate.
12. The use according to claim 11, characterized in that When starch is used as a substrate, the reaction system contains the following enzymes: glucan phosphorylase, glucose phosphomutase, glucose phosphomutase, isoamylase, glucanotransferase, psicose 3-epimerase and the phosphatase mutant as claimed in claim 1.
13. The use according to claim 12, characterized in that The reaction system contains starch, Mg 2+ , glucan phosphorylase, glucose phosphomutase, glucose phosphomutase, isoamylase, glucanotransferase, psicose 3-epimerase and the phosphatase mutant as claimed in claim 1.
14. The use according to claim 11, characterized in that When sucrose is used as a substrate, the reaction system contains the following enzymes: sucrose phosphorylase, glucose phosphomutase, glucose phosphomumerase, psicose 3-epimerase and the phosphatase mutant as claimed in claim 1.
15. The use according to claim 14, characterized in that The reaction system contains sucrose, Mg 2+ , ATP, and sucrose phosphorylase, glucose phosphomutase, glucose phosphomerase, psicose 3-epimerase and the phosphatase mutant as claimed in claim 1.
16. The use according to any one of claims 2 to 14, characterized in that The reaction was carried out at 50-60°C for 16-32 hours. After the reaction was completed, heating was performed in a boiling water bath to terminate the reaction.
Citation Information
Cited By
Method for improving growth density and enzyme yield of glucose-6-phosphate isomerase strain produced by escherichia coli
CN120290445A
